Press releases
* (R) = Regulatory press releases
Aug 23, 2019
(R) Cantargia and BioWa extend ongoing collaboration around the POTELLIGENT® Technology
Aug 22, 2019
(R) Cantargia publishes half year report
Jul 4, 2019
(R) Cantargia announce full recruitment of CAN04 monotherapy arm in ongoing phase IIa clinical trial
May 27, 2019
(R) Annual General Meeting in Cantargia AB (publ)
May 15, 2019
(R) Cantargia: abstract published for the oral presentation of antibody CAN04 phase I data at ASCO
May 13, 2019
(R) Cantargia signs agreement with Patheon Biologics B.V. for production of antibody CAN04
Apr 30, 2019
